SLUG is a direct transcriptional repressor of PTEN tumor suppressor

Prostate

Volumn 75, Issue 9, 2015, Pages 907-916

  Uygur, Berna ^a,b,c   Abramo, Katrina ^a   Leikina, Evgenia ^c   Vary, Calvin ^a   Liaw, Lucy ^a   Wu, Wen Shu ^a,d  

^a Maine Medical Center Research Institute   (United States)

^b UNIVERSITY OF MAINE   (United States)

^c Institute of Child Health and Human Development   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

Author keywords

cell growth; prostate cancer; PTEN; slug; tumor suppressor

Indexed keywords

DNA FRAGMENT; DOXORUBICIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; RETROVIRUS VECTOR; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR SLUG; PTEN PROTEIN, HUMAN; RNA; SMALL INTERFERING RNA; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CANCER RESISTANCE; CARBOXY TERMINAL SEQUENCE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; DRUG SENSITIVITY; E BOX ELEMENT; EMBRYO; ENZYME PHOSPHORYLATION; FIBROBLAST; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LENTIVIRINAE; LUCIFERASE ASSAY; MALE; MOUSE; MOUSE EMBRYO; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER CELL LINE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; KNOCKOUT MOUSE; METABOLISM; PROSTATE TUMOR; TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; PTEN PHOSPHOHYDROLASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS;

EID: 84930007268     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22974     Document Type: Article

References (34)

1. Deocampo ND, Huang H, Tindall DJ,. The role of PTEN in the progression and survival of prostate cancer. Minerva Endocrinol 2003; 28 (2): 145-153.
2. Dahia PL,. PTEN, a unique tumor suppressor gene. Endocr Relat Cancer 2000; 7 (2): 115-129.
3. Suzuki H, Freije D, Nusskern DR, Okami K, Cairns P, Sidransky D, Isaacs WB, Bova GS,. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res 1998; 58 (2): 204-209.
4. Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, Jiao J, Thomas GV, Li G, Roy-Burman P, Nelson PS, Liu X, Wu H,. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 2003; 4 (3): 209-221.
5. Hill R, Wu H,. PTEN, stem cells, and cancer stem cells. J Biol Chem 2009; 284 (18): 11755 -11759.
6. Dubrovska A, Kim S, Salamone RJ, Walker JR, Maira SM, Garcia-Echeverria C, Schultz PG, Reddy VA,. The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci USA 2009; 106 (1): 268-273.
7. Wang S, Garcia AJ, Wu M, Lawson DA, Witte ON, Wu H,. Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation. Proc Natl Acad Sci USA 2006; 103 (5): 1480-1485.
8. Hemavathy K, Ashraf SI, Ip YT,. Snail/slug family of repressors: Slowly going into the fast lane of development and cancer. Gene 2000; 257 (1): 1-12.
9. Wu WS, Heinrichs S, Xu D, Garrison SP, Zambetti GP, Adams JM, Look AT,. Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell 2005; 123 (4): 641-653.
10. Savagner P, Yamada KM, Thiery JP,. The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J Cell Biol 1997; 137 (6): 1403-1419.
11. Uygur B, Wu WS,. SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis. Mol Cancer 10: 139.
12. Camp ER, Findlay VJ, Vaena SG, Walsh J, Lewin DN, Turner DP, Watson DK,. Slug expression enhances tumor formation in a noninvasive rectal cancer model. J Surg Res 170 (1): 56-63.
13. Perez-Mancera PA, Gonzalez-Herrero I, Perez-Caro M, Gutierrez-Cianca N, Flores T, Gutierrez-Adan A, Pintado B, Sanchez-Martin M, Sanchez-Garcia I,. SLUG in cancer development. Oncogene 2005; 24 (19): 3073-3082.
14. Emadi Baygi M, Soheili ZS, Essmann F, Deezagi A, Engers R, Goering W, Schulz WA,. Slug/SNAI2 regulates cell proliferation and invasiveness of metastatic prostate cancer cell lines. Tumour Biol 31 (4): 297-307.
15. Kurrey NK, Jalgaonkar SP, Joglekar AV, Ghanate AD, Chaskar PD, Doiphode RY, Bapat SA,. Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells 2009; 27 (9): 2059-2068.
16. Inoue A, Seidel MG, Wu W, Kamizono S, Ferrando AA, Bronson RT, Iwasaki H, Akashi K, Morimoto A, Hitzler JK, Pestina TI, Jackson CW, Tanaka R, Chong MJ, McKinnon PJ, Inukai T, Grosveld GC, Look AT,. Slug, a highly conserved zinc finger transcriptional repressor, protects hematopoietic progenitor cells from radiation-induced apoptosis in vivo. Cancer Cell 2002; 2 (4): 279-288.
17. Schmittgen TD, Livak KJ,. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3 (6): 1101-1108.
18. Kajita M, McClinic KN, Wade PA,. Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress. Mol Cell Biol 2004; 24 (17): 7559-7566.
19. Haslehurst AM, Koti M, Dharsee M, Nuin P, Evans K, Geraci J, Childs T, Chen J, Li J, Weberpals J, Davey S, Squire J, Park PC, Feilotter H,. EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer. BMC Cancer 12: 91.
20. Chang TH, Tsai MF, Su KY, Wu SG, Huang CP, Yu SL, Yu YL, Lan CC, Yang CH, Lin SB, Wu CP, Shih JY, Yang PC,. Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor. Am J Respir Crit Care Med 2011; 183 (8): 1071-1079.
21. Mancini M, Petta S, Iacobucci I, Salvestrini V, Barbieri E, Santucci MA,. Zinc-finger transcription factor slug contributes to the survival advantage of chronic myeloid leukemia cells. Cell Signal 2010; 22 (8): 1247-1253.
22. Wu HJ, Wu HT, Weng DH, Xing H, Lu YP, Ma D. [Reversal of drug resistance in human ovarian cancer cells by wild-type PTEN gene and its mechanisms]. Zhonghua Fu Chan Ke Za Zhi 2007;42(9):612-616.
23. Steelman LS, Navolanic PM, Sokolosky ML, Taylor JR, Lehmann BD, Chappell WH, Abrams SL, Wong EW, Stadelman KM, Terrian DM, Leslie NR, Martelli AM, Stivala F, Libra M, Franklin RA, McCubrey JA,. Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors. Oncogene 2008; 27 (29): 4086-4095.
24. McCubrey JA, Steelman LS, Abrams SL, Lee JT, Chang F, Bertrand FE, Navolanic PM, Terrian DM, Franklin RA, D'Assoro AB, Salisbury JL, Mazzarino MC, Stivala F, Libra M,. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance. Adv Enzyme Regul 2006; 46: 249-279.
25. Lake F,. Outsmarting glioblastoma: Phosphorylation of PTEN may be a marker of drug resistance. Biomark Med 2012; 6 (5): 638.
26. Bouali S, Chretien AS, Ramacci C, Rouyer M, Becuwe P, Merlin JL,. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells. Oncol Rep 2009; 21 (3): 731-735.
27. Ohigashi T, Mizuno R, Nakashima J, Marumo K, Murai M,. Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN-mutated prostate cancer cells. Prostate 2005; 62 (1): 61-68.
28. Van de Sande T, De Schrijver E, Heyns W, Verhoeven G, Swinnen JV,. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells. Cancer Res 2002; 62 (3): 642 -646.
29. Korsten H, Ziel-van der Made, Ma A, van der Kwast X, Trapman T,. Accumulating progenitor cells in the luminal epithelial cell layer are candidate tumor initiating cells in a Pten knockout mouse prostate cancer model. PLoS ONE 2009; 4 (5): e5662.
30. Lawson DA, Xin L, Lukacs R, Xu Q, Cheng D, Witte ON,. Prostate stem cells and prostate cancer. Cold Spring Harb Symp Quant Biol 2005; 70: 187-196.
31. Stambolic V, MacPherson D, Sas D, Lin Y, Snow B, Jang Y, Benchimol S, Mak TW,. Regulation of PTEN transcription by p53. Mol Cell 2001; 8 (2): 317 -325.
32. Baron V, Adamson ED, Calogero A, Ragona G, Mercola D,. The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. Cancer Gene Ther 2006; 13 (2): 115-124.
33. Virolle T, Adamson ED, Baron V, Birle D, Mercola D, Mustelin T, de Belle I,. The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling. Nat Cell Biol 2001; 3 (12): 1124-1128.
34. Escriva M, Peiro S, Herranz N, Villagrasa P, Dave N, Montserrat-Sentis B, Murray SA, Franci C, Gridley T, Virtanen I, Garcia de Herreros A,. Repression of PTEN phosphatase by Snail1 transcriptional factor during gamma radiation-induced apoptosis. Mol Cell Biol 2008; 28 (5): 1528-1540.